$25.88▾ 1.11%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$-477.82MTTM operating cash
Pre-profit
It is still burning cash while pre-profit.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Lowdebt to assets
Healthy
A modest, well-covered debt load.
More coming: dilution / share-count creep.
✦ The read
Dyne Therapeutics, Inc. is pre-profit. It is still burning cash while pre-profit. A modest, well-covered debt load.
Key numbers
Valuation
EPS (TTM)$-3.30
TTM (trailing 12 months, through fiscal Q2 FY2026)
Size
Revenue (TTM)$0.00
TTM (trailing 12 months, through fiscal Q2 FY2026)
Recent news
Sentiment · last 30 days2 articles
1 bullish1 neutral0 bearish
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock
Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?- Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean
Signals and key numbers are from the fiscal Q2 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.